Clinical Trial Update: A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a two-part Phase 1/Phase 2 study evaluating two doses of golexanolone in adults with primary biliary cholangitis (PBC) who …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Golexanolone (golexanolone)

Snippet

Sponsor: Umecrine Cognition AB | Conditions: Primary Biliary Cholangitis (PBC) | Phase 1, Phase 2 | Status: RECRUITING